| Shaun D Demers, APRN | |
|
82 E View Ln, Cvmc Family Psychiatry, Barre, VT 05641-5332 | |
| (802) 225-1266 | |
| (802) 479-3548 |
| Full Name | Shaun D Demers |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 24 Years |
| Location | 82 E View Ln, Barre, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083681167 | NPI | - | NPPES |
| 28387344002001 | Other | UT | BCBS UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WP0809X | Registered Nurse - Psychiatric/mental Health, Adult | 101.0123357 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Vermont Medical Center | Barre, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Vermont Medical Center Inc | 9335138817 | 204 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologic License Application (BLA) for Neutroval™ (granulocyte colony-stimulating factor) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
Climbing suicide rates over the past ten years have prompted three Joint Commission Sentinel Event Alerts - the most recent in February 2016 - urging health care organizations to step up screening and detection of those individuals most at risk. But due to a shortage of both time and psychiatry staff, complying with this mandate presents a challenge.
As the number of women having twins has increased, so has the odds of developing a serious pregnancy complication called twin-to-twin transfusion syndrome (TTTS). This disorder affects as many as 15 percent of identical twin pregnancies, and results in uneven blood flow between the fetuses. Until recently the outcome was usually death or disabilities for the surviving babies.
Allergan plc, a leading global pharmaceutical company, announced today that new data on the investigational medication rapastinel (GLYX-13) and its lack of impairment on cognitive function were published in the peer-reviewed journal Behavioural Brain Research.
The Wall Street Journal: "State governments expect tax collections to grow for the first time in two years as tax increases and a recovering economy lead to higher collections. But states are still likely to face at least two more years of financial troubles and about half will see gaps in this year's budgets if Congress doesn't extend special Medicaid payments that were part of the 2009 stimulus act, according to a report expected to be released Tuesday by the National Conference of State Legislatures.
› Verified 7 days ago
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831374362 PECOS PAC ID: 9335138817 Enrollment ID: O20040510001034 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologic License Application (BLA) for Neutroval™ (granulocyte colony-stimulating factor) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
Climbing suicide rates over the past ten years have prompted three Joint Commission Sentinel Event Alerts - the most recent in February 2016 - urging health care organizations to step up screening and detection of those individuals most at risk. But due to a shortage of both time and psychiatry staff, complying with this mandate presents a challenge.
As the number of women having twins has increased, so has the odds of developing a serious pregnancy complication called twin-to-twin transfusion syndrome (TTTS). This disorder affects as many as 15 percent of identical twin pregnancies, and results in uneven blood flow between the fetuses. Until recently the outcome was usually death or disabilities for the surviving babies.
Allergan plc, a leading global pharmaceutical company, announced today that new data on the investigational medication rapastinel (GLYX-13) and its lack of impairment on cognitive function were published in the peer-reviewed journal Behavioural Brain Research.
The Wall Street Journal: "State governments expect tax collections to grow for the first time in two years as tax increases and a recovering economy lead to higher collections. But states are still likely to face at least two more years of financial troubles and about half will see gaps in this year's budgets if Congress doesn't extend special Medicaid payments that were part of the 2009 stimulus act, according to a report expected to be released Tuesday by the National Conference of State Legislatures.
› Verified 7 days ago
| Entity Name | Central Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023028784 PECOS PAC ID: 9335138817 Enrollment ID: O20051220000393 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologic License Application (BLA) for Neutroval™ (granulocyte colony-stimulating factor) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
Climbing suicide rates over the past ten years have prompted three Joint Commission Sentinel Event Alerts - the most recent in February 2016 - urging health care organizations to step up screening and detection of those individuals most at risk. But due to a shortage of both time and psychiatry staff, complying with this mandate presents a challenge.
As the number of women having twins has increased, so has the odds of developing a serious pregnancy complication called twin-to-twin transfusion syndrome (TTTS). This disorder affects as many as 15 percent of identical twin pregnancies, and results in uneven blood flow between the fetuses. Until recently the outcome was usually death or disabilities for the surviving babies.
Allergan plc, a leading global pharmaceutical company, announced today that new data on the investigational medication rapastinel (GLYX-13) and its lack of impairment on cognitive function were published in the peer-reviewed journal Behavioural Brain Research.
The Wall Street Journal: "State governments expect tax collections to grow for the first time in two years as tax increases and a recovering economy lead to higher collections. But states are still likely to face at least two more years of financial troubles and about half will see gaps in this year's budgets if Congress doesn't extend special Medicaid payments that were part of the 2009 stimulus act, according to a report expected to be released Tuesday by the National Conference of State Legislatures.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shaun D Demers, APRN Po Box 547, Attn Finance Department, Barre, VT 05641-0547 Ph: (802) 225-1266 | Shaun D Demers, APRN 82 E View Ln, Cvmc Family Psychiatry, Barre, VT 05641-5332 Ph: (802) 225-1266 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter for the Biologic License Application (BLA) for Neutroval™ (granulocyte colony-stimulating factor) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
Climbing suicide rates over the past ten years have prompted three Joint Commission Sentinel Event Alerts - the most recent in February 2016 - urging health care organizations to step up screening and detection of those individuals most at risk. But due to a shortage of both time and psychiatry staff, complying with this mandate presents a challenge.
As the number of women having twins has increased, so has the odds of developing a serious pregnancy complication called twin-to-twin transfusion syndrome (TTTS). This disorder affects as many as 15 percent of identical twin pregnancies, and results in uneven blood flow between the fetuses. Until recently the outcome was usually death or disabilities for the surviving babies.
Allergan plc, a leading global pharmaceutical company, announced today that new data on the investigational medication rapastinel (GLYX-13) and its lack of impairment on cognitive function were published in the peer-reviewed journal Behavioural Brain Research.
The Wall Street Journal: "State governments expect tax collections to grow for the first time in two years as tax increases and a recovering economy lead to higher collections. But states are still likely to face at least two more years of financial troubles and about half will see gaps in this year's budgets if Congress doesn't extend special Medicaid payments that were part of the 2009 stimulus act, according to a report expected to be released Tuesday by the National Conference of State Legislatures.
› Verified 7 days ago
Solenne Thompson, IBCLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 130 Fisher Rd, Barre, VT 05641 Phone: 802-371-4551 | |
Briana Marie Bouffard, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 12 Tamarack Ln, Barre, VT 05641 Phone: 802-595-3479 | |
Katherine Amey, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 82 E View Ln Ste 3, Barre, VT 05641 Phone: 802-225-1266 |